Use of ClearGuard HD caps in pediatric hemodialysis patients

Amy Nau, Troy Richardson, Diana Cardwell, Jennifer Ehrlich, Jyothsna Gattineni, Melisha Hanna, Mahima Keswani, Emily Neibauer, Kelly Nitz, Raymond Quigley, Michelle Rheault, Rebekah Sims, Mayna Woo, Bradley A. Warady

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Bloodstream infections (BSIs) are a leading cause of hospitalizations and mortality among patients receiving hemodialysis (HD) therapy, especially those with a central venous catheter (CVC) for dialysis access. The use of chlorhexidine impregnated catheter caps (ClearGuard) has been associated with a decrease in the rate of HD catheter-related BSIs (CA-BSIs) in adults; similar data have not been published for children. Methods: We compared CA-BSI data from participating centers within the Standardizing Care to Improve Outcomes in Pediatric Endstage Kidney Disease (SCOPE) collaborative based on the center’s use of ClearGuard caps for patients with HD catheter access. Centers were characterized as ClearGuard (CG) or non-ClearGuard (NCG) centers, with CA-BSI data pre- and post-CG implementation reviewed. All positive blood cultures in participating centers were reported to the SCOPE collaborative and adjudicated by an infectious disease physician. Results: Data were available from 1786 SCOPE enrollment forms completed January 2016–January 2022. January 2020 served as the implementation date for analyzing CG versus NCG center data, with this being the time when the last CG center underwent implementation. Post January 2020, there was a greater decrease in the rate of HD CA-BSI in CG centers versus NCG centers, with a decrease from 1.18 to 0.23 and 0.41 episodes per 100 patient months for the CG and NCG centers, respectively (p = 0.002). Conclusions: Routine use of ClearGuard caps in pediatric dialysis centers was associated with a reduction of HD CA-BSI rates in pediatric HD patients. Graphical abstract: (Figure presented.)

Original languageEnglish (US)
Pages (from-to)2171-2175
Number of pages5
JournalPediatric Nephrology
Volume39
Issue number7
DOIs
StatePublished - Jul 2024
Externally publishedYes

Bibliographical note

Publisher Copyright:
© The Authors 2024. corrected publication 2024.

Keywords

  • CA-BSI
  • Cap
  • ClearGuard
  • Hemodialysis
  • Pediatric

PubMed: MeSH publication types

  • Journal Article
  • Multicenter Study

Fingerprint

Dive into the research topics of 'Use of ClearGuard HD caps in pediatric hemodialysis patients'. Together they form a unique fingerprint.

Cite this